Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Letters to the Editor
You have accessRestricted Access

Authors’ Reply

Manjula Kurella Tamura, Nicholas Pajewski and Daniel E. Weiner
JASN December 2020, 31 (12) 2966; DOI: https://doi.org/10.1681/ASN.2020081189
Manjula Kurella Tamura
1Stanford University School of Medicine and Veterans Affairs Palo Alto, Palo Alto, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manjula Kurella Tamura
Nicholas Pajewski
2Wake Forest School of Medicine, Winston-Salem, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel E. Weiner
3Tufts Medical Center, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading
  • chronic kidney disease

Gupta and Burns1 propose the null association between baseline eGFR <60 ml/min per 1.73 m2 and risk for dementia in SPRINT may be attributable to the diminished predictive power of a single eGFR measurement in a population at high vascular risk.

Due to the bidirectional relation between kidney disease and vascular disease, disentangling their respective contributions to the development of cognitive impairment is challenging in observational studies. A strength of SPRINT, in this regard, is that two major vascular risk factors that confound prior studies of kidney disease and cognition, diabetes and hypertension, are limited by the study’s exclusion criteria and controlled by the intervention, respectively.

The SPRINT analysis also differed from two of the prior studies they cite in its use of adjudicated dementia and mild cognitive impairment (MCI) as the primary outcomes. The Health, Aging and Body Composition Study and the INVADE study each used a surrogate for MCI, change in a single cognitive test score, as the primary outcome.1 Although elevated vascular risk was an inclusion criteria in SPRINT, it should be noted that the incidence of dementia in SPRINT, 7.2–8.6 cases per 1000 person-years, was lower than that observed in prior cohort studies, such as the Cardiovascular Health Study (26 cases per 1000 person-years)2 and the 3C Study (12 per 1000 person-years).3 This may be explained by the younger average age and exclusion of individuals with diabetes in SPRINT. Thus, compared with prior observational studies that have reported an association between eGFR and cognitive impairment, SPRINT differed both in its ability to control for potential confounders, and in the frequency and stringency of the outcome. Both of these factors may have contributed to the observation of a null association.

As indicated in the supplemental material, although we did not observe a significant association between eGFR <60 ml/min per 1.73 m2 and risk for dementia or MCI in SPRINT, there was a significant association between baseline eGFR <45 ml/min per 1.73 m2 and risk for MCI (hazard ratio, 1.37; 95% CI, 1.04 to 1.81), and the composite outcome (hazard ratio, 1.34; 95% CI, 1.06 to 1.69). We hypothesize, similar to prediction of kidney failure risk,4 trajectory of eGFR and current eGFR may add complementary information to prediction of dementia risk.

Disclosures

All authors have nothing to disclose.

Funding

M. Kurella Tamura is supported by National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK092241. N. Pajewski reports National Institute on Aging grant R01AG055606 and Alzheimer’s Association grants, during the conduct of the study. D. Weiner reports University of Utah grants, during the conduct of the study.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related Letters to the Editor, “A Single Point-in-Time eGFR Is Not Associated with Increased Risk of Dementia in the Elderly,” on page 2965.

  • Copyright © 2020 by the American Society of Nephrology

References

  1. ↵
    1. Gupta A,
    2. Burns J
    : A single point-in-time eGFR is not associated with increased risk of dementia in the elderly. J Am Soc Nephrol 31:2965, 2020
  2. ↵
    1. Seliger SL,
    2. Siscovick DS,
    3. Stehman-Breen CO,
    4. Gillen DL,
    5. Fitzpatrick A,
    6. Bleyer A, et al
    .: Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol 15: 1904–1911, 2004 pmid:15213280
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Helmer C,
    2. Stengel B,
    3. Metzger M,
    4. Froissart M,
    5. Massy ZA,
    6. Tzourio C, et al
    .: Chronic kidney disease, cognitive decline, and incident dementia: The 3C study. Neurology 77: 2043–2051, 2011 pmid:22116945
    OpenUrlCrossRefPubMed
  4. ↵
    1. Kovesdy CP,
    2. Coresh J,
    3. Ballew SH,
    4. Woodward M,
    5. Levin A,
    6. Naimark DMJ, et al.: CKD Prognosis Consortium
    : Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol 27: 2447–2455, 2016 pmid:26657867
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 31 (12)
Journal of the American Society of Nephrology
Vol. 31, Issue 12
December 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Authors’ Reply
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Authors’ Reply
Manjula Kurella Tamura, Nicholas Pajewski, Daniel E. Weiner
JASN Dec 2020, 31 (12) 2966; DOI: 10.1681/ASN.2020081189

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Authors’ Reply
Manjula Kurella Tamura, Nicholas Pajewski, Daniel E. Weiner
JASN Dec 2020, 31 (12) 2966; DOI: 10.1681/ASN.2020081189
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Funding
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Authors' Reply
  • Remdesivir in COVID-19 Patients with Impaired Renal Function
  • Authors’ Reply
Show more Letters to the Editor

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • A Single Point-in-Time eGFR Is Not Associated with Increased Risk of Dementia in the Elderly
  • PubMed
  • Google Scholar

Keywords

  • chronic kidney disease

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire